Identifying and characterising sources of variability in digital outcome measures in Parkinson’s disease

Smartphones and wearables are widely recognised as the foundation for novel Digital Health Technologies (DHTs) for the clinical assessment of Parkinson’s disease. Yet, only limited progress has been made towards their regulatory acceptability as effective drug development tools. A key barrier in ach...

Descripción completa

Detalles Bibliográficos
Autores principales: Roussos, George, Herrero, Teresa Ruiz, Hill, Derek L., Dowling, Ariel V., L. T. M. Müller, Martijn, Evers, Luc J. W., Burton, Jackson, Derungs, Adrian, Fisher, Katherine, Kilambi, Krishna Praneeth, Mehrotra, Nitin, Bhatnagar, Roopal, Sardar, Sakshi, Stephenson, Diane, Adams, Jamie L., Ray Dorsey, E., Cosman, Josh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284971/
https://www.ncbi.nlm.nih.gov/pubmed/35840653
http://dx.doi.org/10.1038/s41746-022-00643-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284971/
https://www.ncbi.nlm.nih.gov/pubmed/35840653
http://dx.doi.org/10.1038/s41746-022-00643-4

Ejemplares similares